Cargando…

Increase of Soluble Programmed Cell Death Ligand 1 in Patients with Chronic Hepatitis C

Objectives: To determine whether the soluble programmed cell death ligand 1 (sPD-L1) levels in patients with chronic hepatitis C (CHC) are associated with the clinical features of the disease and the efficacy of treatment, including interferon (IFN)-α. Methods: We investigated the sPD-L1 levels in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamagiwa, Satoshi, Ishikawa, Toru, Waguri, Nobuo, Sugitani, Soichi, Kamimura, Kenya, Tsuchiya, Atsunori, Takamura, Masaaki, Kawai, Hirokazu, Terai, Shuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441031/ https://www.ncbi.nlm.nih.gov/pubmed/28539815 http://dx.doi.org/10.7150/ijms.18784

Ejemplares similares

Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial
por: Kamimura, Kenya, et al.
Publicado: (2017)

Spontaneous regression of hepatocellular carcinoma: A mini-review
por: Sakamaki, Akira, et al.
Publicado: (2017)

Bleeding from a Small-Intestinal Ulcer Associated with Chronic Hepatitis C
por: Kamimura, Hiroteru, et al.
Publicado: (2018)

Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient
por: Sakamaki, Akira, et al.
Publicado: (2017)

Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses
por: Kamimura, Kenya, et al.
Publicado: (2017)

Renal Impairment in Chronic Hepatitis B: A Review
por: Kamimura, Hiroteru, et al.
Publicado: (2018)

Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies
por: Kobayashi, Takamasa, et al.
Publicado: (2018)

Prognostic value of subcutaneous adipose tissue volume in hepatocellular carcinoma treated with transcatheter intra-arterial therapy
por: Kobayashi, Takamasa, et al.
Publicado: (2018)

Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C
por: Yamagiwa, Satoshi, et al.
Publicado: (2017)

Longitudinal increase in albumin–bilirubin score is associated with non-malignancy-related mortality and quality of life in patients with liver cirrhosis
por: Sakamaki, Akira, et al.
Publicado: (2022)

A Case of Hepatorenal Syndrome and Abdominal Compartment Syndrome with High Renal Congestion
por: Kamimura, Hiroteru, et al.
Publicado: (2017)

A safe and effective dose of cisplatin in hepatic arterial infusion chemotherapy for hepatocellular carcinoma
por: Osaki, Akihiko, et al.
Publicado: (2013)

Molecular Mechanisms and Treatment of Sarcopenia in Liver Disease: A Review of Current Knowledge
por: Kamimura, Hiroteru, et al.
Publicado: (2021)

Invasive Liver Abscess Syndrome Caused by Klebsiella pneumoniae
por: Setsu, Toru, et al.
Publicado: (2017)

A case report of psychiatric symptoms following direct-acting antiviral and ribavirin combination therapy for chronic hepatitis C in a patient with innate anxiety
por: Sakamaki, Akira, et al.
Publicado: (2019)

Use of a Deep Learning Approach for the Sensitive Prediction of Hepatitis B Surface Antigen Levels in Inactive Carrier Patients
por: Kamimura, Hiroteru, et al.
Publicado: (2022)

Adipose most abundant 2 protein is a predictive marker for cisplatin sensitivity in cancers
por: Kamimura, Kenya, et al.
Publicado: (2021)

Prognostic study of acute-on-chronic liver failure patients: Usefulness of the fibrosis-4 index
por: Watanabe, Yusuke, et al.
Publicado: (2022)

Stomach Dysfunction Is a Potential Risk Factor for Wernicke's Encephalopathy
por: Nakano, Oki, et al.
Publicado: (2016)

Considerations of elderly factors to manage the complication of liver cirrhosis in elderly patients
por: Kamimura, Kenya, et al.
Publicado: (2019)

Rational arrangement of measuring shear wave speed in the liver
por: Yokoo, Takeshi, et al.
Publicado: (2019)

Effect of double platinum agents, combination of miriplatin-transarterial oily chemoembolization and cisplatin-hepatic arterial infusion chemotherapy, in patients with hepatocellular carcinoma: Report of two cases
por: Ogawa, Kohei, et al.
Publicado: (2017)

Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma
por: Kamimura, Kenya, et al.
Publicado: (2012)

The prognosis and incidence of hepatic encephalopathy of patients with liver cirrhosis treated with proton pump inhibitors: A multicenter retrospective study in Japan
por: Sakamaki, Akira, et al.
Publicado: (2021)

Clinical outcome of hepatocellular carcinoma can be predicted by the expression of hepatic progenitor cell markers and serum tumour markers
por: Seino, Satoshi, et al.
Publicado: (2018)

Effective prevention of sorafenib-induced hand–foot syndrome by dried-bonito broth
por: Kamimura, Kenya, et al.
Publicado: (2018)

Diversion colitis and pouchitis: A mini-review
por: Tominaga, Kentaro, et al.
Publicado: (2018)

Effective prevention of sorafenib-related vascular damage induced adverse events and maintenance of hepatic function by dried bonito broth and histidine
por: Sakai, Norihiro, et al.
Publicado: (2019)

Small Intestinal Bacterial Overgrowth Diagnosed by a Breath Test and Improved by Rifaximin in a Patient with Hepatic Encephalopathy and Alcoholic Liver Cirrhosis
por: Sakamaki, Akira, et al.
Publicado: (2020)

Hydrogen-producing small intestinal bacterial overgrowth is associated with hepatic encephalopathy and liver function
por: Yokoyama, Kunihiko, et al.
Publicado: (2022)

Early Detection of Hepatocellular Carcinoma Recurrence Using the Highly Sensitive Fucosylated Fraction of Alpha-Fetoprotein
por: Setsu, Toru, et al.
Publicado: (2017)

Cumulative risk of developing a new symptom in patients with primary biliary cholangitis and its impact on prognosis
por: Kimura, Naruhiro, et al.
Publicado: (2022)

Immunohistochemical Character of Hepatic Angiomyolipoma: For Its Management
por: Kobayashi, Yuka, et al.
Publicado: (2013)

Antiprogramed cell death‐1 therapy with microspheres for metastatic liver tumors
por: Kamimura, Hiroteru, et al.
Publicado: (2019)

Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma
por: Honda, Hiroki, et al.
Publicado: (2017)

Changes in Magnetic Resonance Imaging Findings in a Malignant Melanoma Patient
por: Setsu, Toru, et al.
Publicado: (2020)

Obesity and accumulation of subcutaneous adipose tissue are poor prognostic factors in patients with alcoholic liver cirrhosis
por: Sakamaki, Akira, et al.
Publicado: (2020)

Presence of Antibodies against Self Human Leukocyte Antigen Class II Molecules in Autoimmune Hepatitis
por: Yamagiwa, Satoshi, et al.
Publicado: (2014)

Different distribution of mucosal-associated invariant T cells within the human cecum and colon
por: Hama, Isamu, et al.
Publicado: (2019)

EpCAM- and/or NCAM-Expressing Hepatocellular Carcinoma in Which Behavior of Hepatic Progenitor Cell Marker-Positive Cells Are Followed
por: Tsuchiya, Atsunori, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_scpmvafkldi7b91n8lg7hdrq2r